Toso, Christian <br/><br/>
Sirolimus-based immunosuppression is associated with increased survival after liver transplantation for hepatocellular carcinoma.  [electronic resource] 

 -  Hepatology (Baltimore, Md.)  Apr 2010 
 - 1237-43 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1527-3350 
<br/><br/><label>Standard No.: </label>10.1002/hep.23437  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Carcinoma, Hepatocellular--mortality<br/>Female<br/>Humans<br/>Immunosuppression Therapy<br/>Immunosuppressive Agents--therapeutic use<br/>Liver Neoplasms--mortality<br/>Liver Transplantation<br/>Male<br/>Middle Aged<br/>Sirolimus--therapeutic use